161 related articles for article (PubMed ID: 12871453)
1. Platelet functional defects in women with unexplained menorrhagia.
Philipp CS; Dilley A; Miller CH; Evatt B; Baranwal A; Schwartz R; Bachmann G; Saidi P
J Thromb Haemost; 2003 Mar; 1(3):477-84. PubMed ID: 12871453
[TBL] [Abstract][Full Text] [Related]
2. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of haemostatic characteristics of women with unexplained menorrhagia.
Miller CH; Philipp CS; Stein SF; Kouides PA; Lukes AS; Heit JA; Byams VR; Dowling NF; Kulkarni R
Haemophilia; 2011 Jan; 17(1):e223-9. PubMed ID: 21040234
[TBL] [Abstract][Full Text] [Related]
4. Inherited bleeding disorders in Indian women with menorrhagia.
Saxena R; Gupta M; Gupta PK; Kashyap R; Choudhry VP; Bhargava M
Haemophilia; 2003 Mar; 9(2):193-6. PubMed ID: 12614371
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
Chen YC; Chao TY; Cheng SN; Hu SH; Liu JY
Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
[TBL] [Abstract][Full Text] [Related]
6. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women.
Miller CH; Dilley A; Richardson L; Hooper WC; Evatt BL
Am J Hematol; 2001 Jun; 67(2):125-9. PubMed ID: 11343385
[TBL] [Abstract][Full Text] [Related]
7. [Appropriate laboratory investigation in women with menorrhagia].
de Raucourt E; Ternisien C
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S317-28. PubMed ID: 19268209
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
9. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
Weiss HJ
Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779
[TBL] [Abstract][Full Text] [Related]
11. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
12. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.
Stufano F; Baronciani L; Pagliari MT; Franchi F; Cozzi G; Garcia-Oya I; Bucciarelli P; Boscarino M; Peyvandi F
J Thromb Haemost; 2015 Oct; 13(10):1806-14. PubMed ID: 26206100
[TBL] [Abstract][Full Text] [Related]
14. Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Nakajima Y; Nogami K; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M
Haemophilia; 2019 May; 25(3):e174-e179. PubMed ID: 30866149
[TBL] [Abstract][Full Text] [Related]
15. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
Lian EC; Deykin D
Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
[TBL] [Abstract][Full Text] [Related]
17. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.
Riddell AF; Jenkins PV; Nitu-Whalley IC; McCraw AH; Lee CA; Brown SA
Br J Haematol; 2002 Jan; 116(1):187-92. PubMed ID: 11841416
[TBL] [Abstract][Full Text] [Related]
18. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
19. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
